Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

799 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Persistence of IgG response to SARS-CoV-2.
Duysburgh E, Mortgat L, Barbezange C, Dierick K, Fischer N, Heyndrickx L, Hutse V, Thomas I, Van Gucht S, Vuylsteke B, Ariën KK, Desombere I. Duysburgh E, et al. Among authors: thomas i. Lancet Infect Dis. 2021 Feb;21(2):163-164. doi: 10.1016/S1473-3099(20)30943-9. Epub 2020 Dec 17. Lancet Infect Dis. 2021. PMID: 33341124 Free PMC article. No abstract available.
Poor Antibody Response to BioNTech/Pfizer Coronavirus Disease 2019 Vaccination in Severe Acute Respiratory Syndrome Coronavirus 2-Naive Residents of Nursing Homes.
Pannus P, Neven KY, De Craeye S, Heyndrickx L, Vande Kerckhove S, Georges D, Michiels J, Francotte A, Van Den Bulcke M, Zrein M, Van Gucht S, Schmickler MN, Verbrugghe M, Matagne A, Thomas I, Dierick K, Weiner JA, Ackerman ME, Goriely S, Goossens ME, Ariën KK, Desombere I, Marchant A. Pannus P, et al. Among authors: thomas i. Clin Infect Dis. 2022 Aug 24;75(1):e695-e704. doi: 10.1093/cid/ciab998. Clin Infect Dis. 2022. PMID: 34864935 Free PMC article.
The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms.
Goossens ME, Neven KY, Pannus P, Barbezange C, Thomas I, Gucht SV, Dierick K, Schmickler MN, Verbrugghe M, Loon NV, Ariën KK, Marchant A, Goriely S, Desombere I. Goossens ME, et al. Among authors: thomas i. Arch Public Health. 2021 Nov 11;79(1):195. doi: 10.1186/s13690-021-00715-z. Arch Public Health. 2021. PMID: 34763723 Free PMC article.
Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015-20: a surveillance study.
Fischer N, Dauby N, Bossuyt N, Reynders M, Gérard M, Lacor P, Daelemans S, Lissoir B, Holemans X, Magerman K, Jouck D, Bourgeois M, Delaere B, Quoilin S, Van Gucht S, Thomas I, Barbezange C, Subissi L. Fischer N, et al. Among authors: thomas i. Lancet Microbe. 2021 Mar;2(3):e105-e114. doi: 10.1016/S2666-5247(20)30221-4. Epub 2021 Jan 27. Lancet Microbe. 2021. PMID: 33937883 Free PMC article.
Efficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting: a randomized placebo-controlled phase II trial.
Tobback E, Degroote S, Buysse S, Delesie L, Van Dooren L, Vanherrewege S, Barbezange C, Hutse V, Romano M, Thomas I, Padalko E, Callens S, De Scheerder MA. Tobback E, et al. Among authors: thomas i. Int J Infect Dis. 2022 Sep;122:628-635. doi: 10.1016/j.ijid.2022.06.054. Epub 2022 Jul 5. Int J Infect Dis. 2022. PMID: 35803469 Free PMC article. Clinical Trial.
Spotlight influenza: Extending influenza surveillance to detect non-influenza respiratory viruses of public health relevance: analysis of surveillance data, Belgium, 2015 to 2019.
Subissi L, Bossuyt N, Reynders M, Gérard M, Dauby N, Lacor P, Daelemans S, Lissoir B, Holemans X, Magerman K, Jouck D, Bourgeois M, Delaere B, Quoilin S, Van Gucht S, Thomas I, Barbezange C. Subissi L, et al. Among authors: thomas i. Euro Surveill. 2021 Sep;26(38):2001104. doi: 10.2807/1560-7917.ES.2021.26.38.2001104. Euro Surveill. 2021. PMID: 34558405 Free PMC article.
799 results